Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Mansmann

Showing results (271-280 of 317) with videos related to

Pageof 32
Sort By:
Nature Medicine|August 28, 2022
Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trialKonstantinos D Rizas, Luisa Freyer, Nikolay Sappler, et al.
Wellcome Open Research|October 23, 2018
Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): a single-centre, randomised, double-blind, placebo-controlled trialHaleema Shakur-Still, Ian Roberts, Bukola Fawole, et al.
Diabetes Care|September 15, 2021
Natriuretic Peptides and Risk of Type 2 Diabetes: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) ConsortiumChaterina Sujana, Veikko Salomaa, Frank Kee, et al.
International Journal of Cancer|January 27, 2017
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancerAndreas Herbst, Nikolay Vdovin, Sanja Gacesa, et al.
International Journal of Cancer|April 18, 2026
Development and Release of the Munich UICC Staging Tool (MUST): Advancing UICC Staging in Real-World Data With Insights From Pancreatic and Stomach CancerBrigitte Kühnel, Sophie Schneiderbauer, Sebastian Lange, et al.
Plos One|October 14, 2009
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMDHendrik P N Scholl, Monika Fleckenstein, Lars G Fritsche, et al.
International Journal of Colorectal Disease|November 6, 2016
Laparoscopic versus open distal pancreatectomy-a propensity score-matched analysis from the German StuDoQ|Pancreas registryUlrich Friedrich Wellner, Hryhoriy Lapshyn, Detlef K Bartsch, et al.
Therapeutic Advances in Neurological Disorders|March 30, 2023
Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosisAlexander Hapfelmeier, Begum Irmak On, Mark Mühlau, et al.
International Journal of Cardiology. Heart & Vasculature|July 14, 2021
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stentingLisa Riesinger, Claudia Strobl, David M Leistner, et al.
Stroke|October 30, 2010
Ongoing randomized controlled trials comparing interventional methods and optimal medical treatment in the treatment of asymptomatic carotid stenosisTilman Reiff, Dittmar Böckler, Michael Böhm, et al.
Pageof 32

Showing results (271-280 of 317) with videos related to

Sort By:
Pageof 32
Nature Medicine|August 28, 2022
Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trialKonstantinos D Rizas, Luisa Freyer, Nikolay Sappler, et al.
Wellcome Open Research|October 23, 2018
Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): a single-centre, randomised, double-blind, placebo-controlled trialHaleema Shakur-Still, Ian Roberts, Bukola Fawole, et al.
Diabetes Care|September 15, 2021
Natriuretic Peptides and Risk of Type 2 Diabetes: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) ConsortiumChaterina Sujana, Veikko Salomaa, Frank Kee, et al.
International Journal of Cancer|January 27, 2017
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancerAndreas Herbst, Nikolay Vdovin, Sanja Gacesa, et al.
International Journal of Cancer|April 18, 2026
Development and Release of the Munich UICC Staging Tool (MUST): Advancing UICC Staging in Real-World Data With Insights From Pancreatic and Stomach CancerBrigitte Kühnel, Sophie Schneiderbauer, Sebastian Lange, et al.
Plos One|October 14, 2009
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMDHendrik P N Scholl, Monika Fleckenstein, Lars G Fritsche, et al.
International Journal of Colorectal Disease|November 6, 2016
Laparoscopic versus open distal pancreatectomy-a propensity score-matched analysis from the German StuDoQ|Pancreas registryUlrich Friedrich Wellner, Hryhoriy Lapshyn, Detlef K Bartsch, et al.
Therapeutic Advances in Neurological Disorders|March 30, 2023
Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosisAlexander Hapfelmeier, Begum Irmak On, Mark Mühlau, et al.
International Journal of Cardiology. Heart & Vasculature|July 14, 2021
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stentingLisa Riesinger, Claudia Strobl, David M Leistner, et al.
Stroke|October 30, 2010
Ongoing randomized controlled trials comparing interventional methods and optimal medical treatment in the treatment of asymptomatic carotid stenosisTilman Reiff, Dittmar Böckler, Michael Böhm, et al.
Pageof 32